Cytosorbents Corporation (CTSO) Stock Forecast
Data as of Sep 20, 2026Healthcare · Current price $5.52 (-4.17%)
Consensus Target
—
Upside
—
Analysts
1
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
6-Month Trend
No rating trend data.
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
CTSO vs Sector & Market
| Metric | CTSO | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | — | +22217.1% | +21.5% |
| P/E Ratio | -4.60 | 3.77 | 38.34 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $40M | $41M | $41M | 2 |
| 2027-12-31 | $48M | $49M | $50M | 1 |
| 2028-12-31 | $56M | $57M | $58M | 2 |
| 2029-12-31 | $72M | $73M | $74M | 1 |
| 2030-12-31 | $131M | $133M | $135M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.23 | $-0.17 | $-0.10 | 2 |
| 2027-12-31 | $-0.06 | $-0.06 | $-0.06 | 1 |
| 2028-12-31 | $-0.04 | $0.01 | $0.07 | 2 |
| 2029-12-31 | $0.14 | $0.14 | $0.14 | 1 |
| 2030-12-31 | $0.57 | $0.58 | $0.59 | 1 |
Frequently Asked Questions
What is the analyst consensus for CTSO?
The consensus among 1 analysts covering Cytosorbents Corporation (CTSO) is Buy with an average price target of N/A.
How many analysts cover CTSO?
1 analysts have issued ratings for Cytosorbents Corporation in the past 12 months.
Is CTSO a buy or sell right now?
Based on 1 analyst ratings, CTSO has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for CTSO?
Analysts estimate CTSO will report EPS of $-0.17 for the period ending 2026-12-31, with revenue estimated at $41M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.